ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6,001 | 69.35498 | 1 | female | 0 | 12 | 523 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 9,907 | 7,324.4648 | 2,639.72852 | 13 | white | 23.296875 | 23 | 0.80188 | 0.679932 | 1 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 12 | 71 | 13.798828 | 130 | 24 | 36.5 | 231.28125 | 3.199707 | 0.399963 | 0.799927 | 136 | 7.369141 | null | null | null | 0 | null | adl>=4 (>=5 if sur) | 0.4948 |
6,002 | 57.435 | 1 | female | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | under $11k | 44 | 9,983 | 7,126.0078 | 4,083.98828 | 46 | black | 33.59375 | 46 | 0.439941 | 0.320984 | 2 | 0 | 0 | no | 0.5 | 0.4 | dnr before sadm | 0 | 67 | 4.399414 | 109 | 24 | 35 | 468 | 1.699951 | 11 | 0.899902 | 132 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,003 | 55.63898 | 1 | male | 1 | 14 | 14 | Lung Cancer | Cancer | 5 | 8 | under $11k | 0 | 13,241 | 9,668.6797 | 4,249.75781 | 14.666664 | white | 19.199219 | 37 | 0.685913 | 0.392944 | 1 | 0 | 0 | metastatic | 0.8 | 0.7 | dnr after sadm | 7 | 77 | 24.097656 | 124 | 30 | 37.39844 | 414.25 | 3.799805 | 0.599976 | 1.099854 | 134 | 7.40918 | null | null | null | 0 | 1 | <2 mo. follow-up | 1 |
6,004 | 36.22198 | 0 | female | 0 | 14 | 1,892 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | null | null | 9 | 12,878 | null | null | 10.666664 | black | 24.398438 | 27 | 0.829956 | 0.7229 | 1 | 0 | 0 | no | 0.99 | 0.9 | no dnr | 14 | 147 | 13.199219 | 114 | 13 | 37.79688 | 294.625 | 3.299805 | 2.799805 | 0.5 | 141 | 7.379883 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
6,005 | 57.91599 | 1 | male | 0 | 5 | 769 | COPD | COPD/CHF/Cirrhosis | 3 | null | under $11k | 0 | 4,528 | 3,296.6719 | 1,637.31934 | 14 | white | 21.398438 | 30 | 0.879883 | 0.800903 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 5 | 63 | 10.398438 | 68 | 24 | 35.89844 | 143.3125 | 3.899902 | 0.899902 | 0.899902 | 132 | 7.399414 | null | null | null | 4 | 0 | no(M2 and SIP pres) | 0 |
6,006 | 59.32397 | 1 | male | 0 | 24 | 1,289 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 10 | under $11k | 0 | 23,591 | 17,805.0156 | 5,815.27734 | 14.666664 | white | 31.5 | 27 | 0.702881 | 0.613892 | 1 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 24 | 119 | 17.296875 | 111 | 28 | 36.5 | 232 | 2.899902 | 0.5 | 0.799927 | 119 | 7.359375 | null | null | null | 2 | 1 | no(M2 and SIP pres) | 1 |
6,007 | 71.07196 | 1 | male | 1 | 5 | 5 | Coma | Coma | 1 | null | under $11k | 100 | 14,385 | 10,782.2812 | 4,525.02734 | 46 | white | 35.796875 | 54 | 0.007999 | 0.003 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 5 | 63 | 8.398438 | 113 | 20 | 39.69531 | 140.59375 | 2.399902 | 2 | 6.399414 | 126 | 7.30957 | null | null | null | null | null | <2 mo. follow-up | 3.21875 |
6,008 | 55.17297 | 1 | male | 0 | 27 | 29 | MOSF w/Malig | ARF/MOSF | 3 | null | null | 0 | 15,683 | 37,632.875 | 20,804.9375 | 30.75 | white | 33.296875 | 55 | 0.367981 | 0.250977 | 15 | 0 | 0 | yes | 0.7 | 0.2 | dnr after sadm | 15 | 60 | 0.109985 | 103 | 24 | 36 | 198.75 | 2.599609 | 2.799805 | 1.599854 | 135 | 7.5 | null | null | null | 2 | null | <2 mo. follow-up | 1.839 |
6,009 | 58.836 | 1 | female | 1 | 53 | 53 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 6 | $11-$25k | 0 | 66,621 | 48,740.4375 | 24,677.6094 | 25 | white | 25.097656 | 37 | 0.774902 | 0.701904 | 5 | 0 | 0 | no | 0.5 | 0.1 | dnr after sadm | 19 | 109 | 11.798828 | 120 | 24 | 38.39844 | 113.23438 | 2 | 0.399963 | 1 | 138 | 7.429688 | null | null | null | 1 | 5 | <2 mo. follow-up | 5 |
6,010 | 67.74298 | 1 | male | 0 | 28 | 221 | ARF/MOSF w/Sepsis | ARF/MOSF | 6 | 9 | null | 44 | 25,813 | 20,529.9531 | 7,342.48828 | 11.25 | black | 19.199219 | 28 | 0.73291 | 0.650879 | 2 | 1 | 0 | no | 0.7 | 0.5 | dnr after sadm | 7 | 79 | 11.898438 | 100 | 12 | 38.29688 | 250 | 3.199707 | 1.299805 | 1.099854 | 134 | 7.429688 | null | null | null | null | 4 | adl>=4 (>=5 if sur) | 4 |
6,011 | 44.47098 | 0 | male | 0 | 26 | 1,886 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 16 | >$50k | 9 | 29,825 | 23,189.625 | 5,431.4375 | 12 | white | 28.898438 | 33 | 0.73291 | 0.649902 | 7 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 26 | 108 | 13 | 129 | 36 | 38.59375 | 157.9375 | 2.299805 | 0.299988 | 0.799927 | 130 | 7.389648 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,012 | 19.44099 | 1 | female | 0 | 27 | 73 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 11 | >$50k | 89 | 26,602 | 19,745.0312 | 8,173.22656 | 23 | white | 28.699219 | 48 | 0.525879 | 0.409973 | 2 | 0 | 0 | yes | 0.7 | 0.5 | dnr after sadm | 1 | 120 | 10.199219 | 153 | 60 | 39.29688 | 217.65625 | 3 | 0.399963 | 0.599976 | 131 | 7.469727 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
6,013 | 28.85699 | 0 | male | 0 | 23 | 1,886 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 48,348 | 33,997.0312 | 16,042.3984 | 52 | white | 32.5 | 45 | 0.80896 | 0.745972 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 23 | 75 | 10.398438 | 115 | 16 | 39.19531 | 93.28125 | 2.799805 | 4.799805 | 1.5 | 141 | 7.279297 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,014 | 46.57098 | 0 | male | 0 | 14 | 1,884 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 8 | $11-$25k | 9 | 10,517 | 8,146.3789 | 2,516.6582 | 4.666664 | white | 17.898438 | 32 | 0.860962 | 0.769897 | 1 | 0 | 0 | no | 0.5 | 0.3 | no dnr | 14 | 72 | 9.099609 | 88 | 22 | 37.79688 | 331.875 | 2.199707 | 3.899902 | 0.699951 | 134 | 7.459961 | null | null | null | 0 | 2 | no(M2 and SIP pres) | 2 |
6,015 | 66.49396 | 1 | female | 0 | 4 | 21 | Lung Cancer | Cancer | 3 | 8 | null | 9 | 2,963 | 2,225.7715 | 1,004.52979 | 6 | white | 21.699219 | 26 | 0.556885 | 0.233978 | 1 | 0 | 0 | metastatic | null | null | dnr before sadm | 0 | 103 | 8 | 77 | 24 | 36.5 | null | null | 0.199982 | 1.899902 | 126 | null | null | null | null | null | 1 | <2 mo. follow-up | 1 |
6,016 | 68.69299 | 1 | female | 0 | 8 | 344 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 10,490 | 7,969.9062 | 2,740.56836 | 16.5 | white | 29.398438 | 32 | 0.699951 | 0.609985 | 1 | 0 | 1 | no | 1 | 0.8 | dnr before sadm | -1 | 108 | 14.298828 | 136 | 36 | 38.5 | 177.125 | 4.299805 | 0.799927 | 0.699951 | 130 | 7.419922 | null | null | null | null | 4 | no(M2 and SIP pres) | 4 |
6,017 | 56.85397 | 1 | female | 0 | 15 | 236 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | $11-$25k | 0 | 12,699 | 9,728.1484 | 2,626.26953 | 15.666664 | white | 24.796875 | 49 | 0.822998 | 0.762939 | 1 | 1 | 0 | no | 1 | 0.95 | no dnr | 15 | 131 | 12.699219 | 83 | 31 | 35.69531 | 314.8125 | 2.199707 | 0.199982 | 2.5 | 133 | 7.389648 | null | null | null | 5 | 6 | no(M2 and SIP pres) | 6 |
6,018 | 65.26495 | 1 | male | 1 | 5 | 5 | CHF | COPD/CHF/Cirrhosis | 5 | 12 | $11-$25k | 44 | 16,432 | 13,072.0391 | 2,839.25977 | 39 | white | 46.898438 | 71 | 0.046997 | 0.004999 | 5 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 3 | 46 | 18.5 | 160 | 38 | 39 | 111.625 | 2.799805 | 1.199951 | 1.5 | 131 | 7.349609 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,019 | 38.43698 | 1 | male | 0 | 16 | 69 | MOSF w/Malig | ARF/MOSF | 1 | 12 | under $11k | 44 | 44,481 | 31,427.0938 | 11,756.7266 | 40 | white | 30.898438 | 45 | 0.17099 | 0.085999 | 12 | 0 | 0 | metastatic | 0.75 | 0.422 | no dnr | 16 | 57 | 28.398438 | 109 | 28 | 38.69531 | 124.4375 | 2 | 0.799927 | 0.899902 | 130 | 7.469727 | null | null | null | null | 5 | null | 5 |
6,020 | 89.36096 | 1 | female | 0 | 4 | 607 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 9 | 2,386 | 1,827.4287 | 497.1499 | 4 | black | 16.5 | 16 | 0.803955 | 0.682983 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 4 | 99 | 6.699219 | 66 | 20 | 36 | 442.8125 | 3.599609 | 0.399963 | 1.5 | 136 | 7.459961 | null | null | null | 1 | 0 | SIP>=30 | 0 |
6,021 | 62.93997 | 1 | female | 0 | 10 | 32 | CHF | COPD/CHF/Cirrhosis | 4 | 11 | under $11k | 0 | 11,791 | 9,143.8281 | 2,908.06836 | 11.5 | white | 19.699219 | 20 | 0.869995 | 0.784912 | 1 | 0 | 0 | no | 0.8 | 0.5 | dnr after sadm | 1 | 110 | 6.199219 | 62 | 34 | 36.29688 | 396.25 | 3.199707 | 0.5 | 1.399902 | 136 | 7.449219 | null | null | null | 3 | 5 | <2 mo. follow-up | 5 |
6,022 | 65.55499 | 1 | male | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 100 | 49,916 | 35,438.4375 | 15,968.5938 | 69 | black | 64.796875 | 91 | 0 | 0 | 18 | 0 | 0 | yes | 0 | 0 | no dnr | 3 | 31 | 58.59375 | 0 | 36 | 38.29688 | 52 | 2.699707 | 5.699219 | 0.599976 | 132 | 7.119141 | null | null | null | null | null | <2 mo. follow-up | 2.962402 |
6,023 | 57.62399 | 0 | female | 0 | 35 | 1,879 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | under $11k | 0 | 71,696 | 56,249.2812 | 13,051.2188 | 27.75 | white | 25.796875 | 20 | 0.764893 | 0.688965 | 6 | 0 | 0 | no | 0.75 | 0.5 | dnr after sadm | 1 | 115 | 19 | 136 | 12 | 38.79688 | 233.96875 | 2.899902 | 0.5 | 0.399963 | 131 | 7.339844 | null | null | null | null | 4 | SIP>=30 | 4 |
6,024 | 77.77698 | 1 | male | 0 | 6 | 18 | Lung Cancer | Cancer | 3 | null | under $11k | 9 | 4,039 | 3,098.3418 | 1,024.61914 | 10 | black | 35.195313 | 17 | 0.141998 | 0.007999 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 96 | 11.599609 | 102 | 20 | 35 | null | 2.699707 | 0.199982 | 0.799927 | 127 | null | null | null | null | null | 7 | <2 mo. follow-up | 7 |
6,025 | 57.16898 | 1 | male | 0 | 36 | 1,548 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 44 | 43,385 | 33,680.7812 | 14,684.6875 | 23.25 | white | 26.398438 | 57 | 0.657959 | 0.559937 | 1 | 0 | 0 | no | 0.8 | 0.75 | dnr after sadm | 4 | 55 | 20.199219 | 68 | 24 | 36.89844 | 342.8125 | 2.399902 | 0.399963 | 3.299805 | 133 | 7.289062 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
6,026 | 70.64795 | 1 | female | 0 | 9 | 504 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | under $11k | 0 | 11,537 | 8,542.9219 | 2,377.1582 | 13 | white | 20.898438 | 20 | 0.829956 | 0.772949 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 9 | 69 | 11 | 55 | 24 | 36.89844 | 185 | 3.699707 | 0.399963 | 0.899902 | 134 | 7.469727 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,027 | 68.12897 | 1 | male | 1 | 24 | 24 | Coma | Coma | 3 | null | null | 100 | 33,190 | 24,041.8281 | 10,818.4375 | 25.333328 | white | 25 | 32 | 0.154999 | 0.102997 | 1 | 0 | 0 | no | 0.4 | 0.3 | dnr after sadm | 6 | 63 | 9.898438 | 77 | 12 | 36.39844 | 143.3125 | 4 | 1.5 | 1.899902 | 133 | 7.379883 | null | null | null | null | null | <2 mo. follow-up | 3.589356 |
6,028 | 19.17599 | 0 | male | 0 | 18 | 1,876 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | null | 0 | 23,266 | 17,812.2812 | 5,496.71875 | 14.666664 | black | 25.097656 | 26 | 0.888916 | 0.849976 | 5 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 18 | 74 | 22.398438 | 111 | 48 | 36.59375 | 320 | 3.099609 | 1.699951 | 0.599976 | 137 | 7.419922 | null | null | null | null | null | null | 2.98877 |
6,029 | 44.698 | 1 | male | 1 | 12 | 12 | MOSF w/Malig | ARF/MOSF | 1 | 12 | $25-$50k | 0 | null | null | null | 26 | white | 33.195313 | 47 | 0.506958 | 0.389954 | 1 | 0 | 0 | yes | 0.75 | 0.5 | null | null | 105 | 0.309998 | 58 | 28 | 36.29688 | null | 3.099609 | 1.199951 | 1.899902 | 130 | null | null | null | null | 2 | 0 | <2 mo. follow-up | 0 |
6,030 | 68.13098 | 1 | female | 0 | 6 | 79 | MOSF w/Malig | ARF/MOSF | 2 | 13 | under $11k | 0 | 23,735 | 16,893.375 | 6,256.94922 | 34 | black | 25.898438 | 38 | 0.494995 | 0.377991 | 8 | 0 | 0 | metastatic | 0.25 | 0.1 | no dnr | 6 | 65 | 16.898438 | 106 | 22 | 36 | 141.71875 | 2.099609 | 0.699951 | 0.799927 | 139 | 7.189453 | null | null | null | 0 | 0 | SIP>=30 | 0 |
6,031 | 75.64996 | 1 | female | 0 | 17 | 323 | COPD | COPD/CHF/Cirrhosis | 3 | 13 | null | 0 | 16,397 | 12,036.5859 | 5,585.35938 | 20.666656 | white | 31.296875 | 48 | 0.590942 | 0.399963 | 1 | 1 | 0 | no | 0.9 | 0.9 | dnr before sadm | -1 | 121 | 43.09375 | 114 | 36 | 36.39844 | 319.1875 | 2.399902 | 0.799927 | 0.899902 | 140 | 7.419922 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
6,032 | 50.90198 | 1 | male | 0 | 6 | 59 | CHF | COPD/CHF/Cirrhosis | 5 | 10 | under $11k | 0 | 4,139 | 3,192.3516 | 1,036.26953 | 11 | black | 22.398438 | 32 | 0.875977 | 0.794922 | 1 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 6 | 106 | 6.099609 | 66 | 25 | 36 | 347.5625 | 3.799805 | 1.699951 | 1.899902 | 130 | 7.439453 | null | null | null | 2 | 2 | <2 mo. follow-up | 2 |
6,033 | 61.46997 | 1 | male | 0 | 24 | 1,423 | CHF | COPD/CHF/Cirrhosis | 6 | 5 | under $11k | 0 | 17,282 | 13,229.7422 | 3,165.04883 | 11 | black | 24.097656 | 38 | 0.824951 | 0.715942 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 24 | 81 | 4.299805 | 65 | 24 | 35.19531 | null | 4.099609 | 9.699219 | 1.599854 | 133 | null | null | null | null | 3 | null | SIP>=30 | 2.511099 |
6,034 | 31.778 | 0 | female | 0 | 5 | 1,871 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | under $11k | 0 | 8,632 | 6,479.1289 | 4,165.17969 | 16 | hispanic | 21.699219 | 15 | 0.898926 | 0.861938 | 3 | 0 | 0 | no | 1 | 1 | no dnr | 5 | 85 | 13.599609 | 107 | 16 | 35.5 | 360 | 2.699707 | 0.099991 | 0.799927 | 143 | 7.279297 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,035 | 58.90997 | 1 | male | 0 | 12 | 469 | CHF | COPD/CHF/Cirrhosis | 5 | 8 | $11-$25k | 0 | 6,866 | 5,545.7188 | 6,756.72656 | 9 | white | 24.5 | 32 | 0.828979 | 0.719971 | 1 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 12 | 107 | 7.899414 | 72 | 20 | 36.19531 | null | 2.599609 | 0.399963 | 2.099609 | 134 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
6,036 | 59.94299 | 1 | male | 0 | 7 | 389 | CHF | COPD/CHF/Cirrhosis | 6 | 8 | null | 0 | 5,369 | 4,071.6289 | 985.38965 | 17 | white | 19.097656 | 36 | 0.883911 | 0.805908 | 1 | 1 | 0 | no | 0.3 | 0.25 | dnr after sadm | 2 | 67 | 8.5 | 58 | 22 | 35.5 | 276.1875 | 3.699707 | 1 | 1.599854 | 137 | 7.459961 | null | null | null | 2 | 3 | null | 3 |
6,037 | 44.36697 | 1 | female | 1 | 7 | 7 | Coma | Coma | 1 | 9 | under $11k | 44 | 34,994 | 27,346.5156 | 6,801.59766 | 46 | white | 21.398438 | 31 | 0.635986 | 0.574951 | 24 | 1 | 0 | no | 0 | 0 | dnr after sadm | 1 | 119 | 9.199219 | 122 | 44 | 38.29688 | 310 | 3.299805 | 0.299988 | 0.599976 | 136 | 7.519531 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
6,038 | 56.82397 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 11,003 | 8,158.1055 | 3,571.9082 | 47 | white | 51.09375 | 80 | 0.192993 | 0.10199 | 1 | 0 | 0 | no | 0.75 | 0.75 | dnr after sadm | 4 | 40 | 18.597656 | 104 | 42 | 36.69531 | 128.3125 | 1.899902 | 1.5 | 4.799805 | 128 | 7.279297 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,039 | 69.81799 | 1 | male | 0 | 28 | 782 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 67,894 | 51,587.5938 | 24,316.0781 | 27.25 | white | 20.097656 | 17 | 0.81189 | 0.748901 | 5 | 0 | 0 | no | 0.98 | 0.98 | no dnr | 28 | 76 | 8 | 64 | 6 | 36.59375 | 190 | 2 | 0.799927 | 1.099854 | 127 | 7.439453 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,040 | 40.82098 | 0 | female | 0 | 12 | 1,870 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | under $11k | 0 | 22,096 | 16,272.7656 | 6,460.19922 | 30 | black | 26.296875 | 56 | 0.810913 | 0.746948 | 8 | 0 | 0 | no | 0.6 | 0.4 | no dnr | 12 | 62 | 27.199219 | 157 | 12 | 37.59375 | 330 | 1.799805 | 0.399963 | 0.299988 | 155 | 7.269531 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
6,041 | 61.862 | 0 | female | 0 | 10 | 1,867 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 16 | $11-$25k | 0 | 7,547 | 5,688.0742 | 1,851.94922 | 10.5 | white | 23.699219 | 34 | 0.714966 | 0.556885 | 1 | 0 | 0 | no | 0.95 | 1 | no dnr | 10 | 65 | 18.097656 | 78 | 24 | 36.59375 | null | 2.899902 | 8.099609 | 0.699951 | 134 | null | null | null | null | null | null | no(M2 and SIP pres) | 3.489746 |
6,042 | 58.21799 | 1 | male | 0 | 3 | 392 | Lung Cancer | Cancer | 1 | 10 | under $11k | 0 | 2,678 | 1,860.1299 | 1,129.20996 | 15 | white | 5.299805 | 9 | 0.882935 | 0.733887 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 3 | 93 | 6.099609 | 82 | 20 | 36.59375 | null | 4.399414 | 0.5 | 0.599976 | 137 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.901856 |
6,043 | 62.85797 | 0 | female | 0 | 54 | 1,867 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | under $11k | 0 | 101,794 | 73,628.625 | 71,763 | 44.5 | white | 28.796875 | 42 | 0.706909 | 0.618896 | 3 | 0 | 0 | no | 0.65 | 0.65 | no dnr | 54 | 60 | 5.399414 | 135 | 25 | 38.29688 | 92.84375 | 2 | 0.5 | 1.099854 | 137 | 7.359375 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,044 | 54.09198 | 0 | male | 0 | 20 | 1,865 | Cirrhosis | COPD/CHF/Cirrhosis | 5 | 11 | under $11k | 37 | 22,227 | 16,526.3438 | 6,487.08984 | 13.333328 | white | 25.597656 | 43 | 0.590942 | 0.399963 | 1 | 1 | 0 | no | 0.8 | 0.6 | dnr after sadm | 9 | 75 | 6.899414 | 124 | 24 | 36 | 476.1875 | 2.599609 | 3.899902 | 1.699951 | 142 | 7.5 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,045 | 65.72797 | 1 | female | 0 | 5 | 33 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 3,533 | 2,659.3281 | 882.76953 | 10 | black | 20.898438 | 33 | 0.849976 | 0.75293 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 5 | 104 | 7.299805 | 60 | 32 | 36.19531 | 242.84375 | null | 0.899902 | 1.899902 | 142 | 7.419922 | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
6,046 | 76.38898 | 0 | female | 0 | 18 | 1,866 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 0 | 36,207 | 26,361.5625 | 10,101.8281 | 13.333328 | white | 25 | 42 | 0.685913 | 0.592896 | 8 | 0 | 0 | no | 0.85 | 0.75 | no dnr | 18 | 103 | 15.898438 | 101 | 20 | 36.29688 | 310 | 1.899902 | 1.599854 | 2.5 | 135 | 7.349609 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,047 | 59.13498 | 1 | female | 0 | 5 | 1,401 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 3,112 | 2,397.3359 | 700.76953 | 10 | white | 20.699219 | 35 | 0.784912 | 0.654907 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 5 | 62 | 6.799805 | 120 | 23 | 36.59375 | null | 2.599609 | 2.099609 | 1.299805 | 135 | null | null | null | null | 0 | 2 | no(M2 and SIP pres) | 2 |
6,048 | 55.474 | 1 | female | 0 | 94 | 257 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | $11-$25k | 0 | 212,445 | 164,982.375 | 159,981.625 | 44.5 | white | 27.296875 | 72 | 0.792969 | 0.724976 | 1 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 94 | 61 | 11.199219 | 133 | 36 | 38.5 | 426 | 2 | 2.299805 | 2.099609 | 136 | 7.469727 | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
6,049 | 54.146 | 1 | female | 0 | 8 | 524 | MOSF w/Malig | ARF/MOSF | 1 | 12 | null | 0 | 27,282 | 19,477.1719 | 9,371.72656 | 21.5 | white | 36.59375 | 45 | 0.264954 | 0.15799 | 19 | 0 | 0 | yes | 0.95 | 0.95 | no dnr | 8 | 91 | 0 | 140 | 28 | 39 | null | 2.5 | 1.399902 | 0.799927 | 125 | null | null | null | null | 0 | 6 | no(M2 and SIP pres) | 6 |
6,050 | 54.883 | 1 | female | 0 | 6 | 261 | CHF | COPD/CHF/Cirrhosis | 4 | 10 | under $11k | 0 | 5,706 | 4,203.7383 | 2,311.34961 | 10 | black | 28.199219 | 34 | 0.792969 | 0.667969 | 1 | 1 | 0 | no | 0.98 | 0.95 | no dnr | 6 | 113 | 8.298828 | 104 | 24 | 36.29688 | 252.375 | 2.599609 | 0.399963 | 2.5 | 137 | 7.359375 | null | null | null | 5 | null | null | 3.855299 |
6,051 | 65.659 | 1 | male | 0 | 51 | 251 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | null | 0 | 71,701 | 55,313.6562 | 55,616.75 | 21.75 | white | 38 | 58 | 0.401978 | 0.282959 | 12 | 1 | 1 | no | 0.5 | 0.5 | no dnr | 51 | 53 | 6.399414 | 118 | 28 | 35.59375 | 133.25 | 2.099609 | 0.399963 | 1.699951 | 130 | 7.489258 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
6,052 | 72.13098 | 0 | female | 0 | 10 | 1,859 | COPD | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 7,997 | 5,999.3281 | 2,242.41992 | 12.5 | white | 20.398438 | 23 | 0.782959 | 0.651978 | 1 | 0 | 0 | yes | 0.5 | 0.4 | dnr after sadm | 1 | 76 | 6.099609 | 114 | 24 | 36.59375 | 202 | 3.399902 | 0.899902 | 1 | 136 | 7.349609 | null | null | null | null | 4 | adl>=4 (>=5 if sur) | 4 |
6,053 | 61.75998 | 1 | male | 0 | 7 | 15 | COPD | COPD/CHF/Cirrhosis | 3 | 0 | under $11k | 0 | 5,883 | 4,348.332 | 1,688.12988 | 8 | white | 20.898438 | 38 | 0.869995 | 0.783936 | 1 | 0 | 0 | no | 0.3 | 0.1 | dnr after sadm | 2 | 71 | 6.199219 | 104 | 22 | 36.29688 | 189.1875 | null | null | 1.399902 | 137 | 7.239258 | null | null | null | 2 | 6 | <2 mo. follow-up | 6 |
6,054 | 59.61099 | 1 | female | 0 | 9 | 81 | CHF | COPD/CHF/Cirrhosis | 4 | 10 | under $11k | 0 | 8,314 | 6,497.7617 | 1,861.3291 | 10.5 | white | 20.097656 | 17 | 0.875977 | 0.792969 | 1 | 1 | 0 | no | 0.95 | 0.9 | no dnr | 9 | 106 | 9.5 | 110 | 22 | 36 | 372 | 3.699707 | 1.199951 | 0.799927 | 134 | 7.379883 | null | null | null | 6 | 4 | SIP>=30 | 4 |
6,055 | 61.76898 | 1 | female | 1 | 27 | 27 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 10 | under $11k | 44 | 105,139 | 75,388.625 | 43,017.6875 | 53.75 | white | 32.195313 | 58 | 0.389954 | 0.270996 | 7 | 1 | 0 | no | 0.5 | 0.5 | dnr after sadm | 27 | 71 | 16.097656 | 128 | 30 | 38 | 92.29688 | 2.399902 | 3.899902 | 1 | 143 | 7.5 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
6,056 | 70.24194 | 0 | female | 0 | 6 | 1,857 | CHF | COPD/CHF/Cirrhosis | 4 | 3 | null | 0 | 4,524 | 3,394.2441 | 1,397.36914 | 12 | black | 10.798828 | 19 | 0.92395 | 0.870972 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 6 | 106 | 9.798828 | 98 | 22 | 36 | 369.5 | 4.599609 | 0.699951 | 1.099854 | 142 | 7.389648 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,057 | 47.51297 | 0 | male | 0 | 12 | 1,855 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 16,698 | 12,657.3438 | 3,547.7793 | 22 | black | 35.195313 | 40 | 0.641968 | 0.461975 | 7 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 12 | 121 | 10.5 | 101 | 14 | 35.59375 | 480.4375 | 2.799805 | 1.399902 | 6.699219 | 126 | 7.489258 | null | null | null | 0 | 4 | SIP>=30 | 4 |
6,058 | 80.76898 | 1 | female | 1 | 20 | 20 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 7 | under $11k | 0 | 43,134 | 33,944.875 | 8,631.48438 | 29 | white | 42.898438 | 50 | 0.260986 | 0.154999 | 1 | 0 | 0 | no | 0.5 | 0.25 | dnr after sadm | 2 | 48 | 16.699219 | 101 | 20 | 36.19531 | 108.32812 | 1.699951 | 2 | 0.5 | 126 | 7.389648 | null | null | null | null | null | <2 mo. follow-up | 2.75 |
6,059 | 59.995 | 0 | female | 0 | 11 | 1,854 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 16,998 | 13,500.625 | 7,232.92969 | 21.5 | null | 25.097656 | 37 | 0.680908 | 0.511963 | 2 | 0 | 0 | no | 0.98 | 0.9 | no dnr | 11 | 104 | 8.699219 | 110 | 30 | 36.79688 | 288.875 | 2.699707 | 6.299805 | 1 | 133 | 7.399414 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,060 | 60.487 | 1 | female | 0 | 14 | 875 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 10 | null | 0 | 46,234 | 38,764.875 | 13,882.6562 | 17.333328 | white | 30.898438 | 38 | 0.571899 | 0.460999 | 7 | 1 | 1 | yes | 1 | 0.8 | no dnr | 14 | 127 | 11.798828 | 50 | 10 | 36.59375 | 146.25 | null | null | 3 | 134 | 7.40918 | null | null | null | null | null | no(M2 and SIP pres) | 5.280273 |
6,061 | 75.58099 | 1 | female | 0 | 8 | 496 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 8,458 | 6,429.4102 | 3,675.22852 | 15.5 | white | 19.898438 | 35 | 0.829956 | 0.7229 | 1 | 1 | 0 | no | 0.7 | 0.5 | no dnr | 8 | 82 | 7.099609 | 72 | 20 | 35.69531 | 394.75 | 3.399902 | 4 | 2 | 134 | 7.40918 | null | null | null | 3 | 1 | SIP>=30 | 1 |
6,062 | 77.44598 | 1 | female | 0 | 24 | 144 | Colon Cancer | Cancer | 2 | 10 | under $11k | 0 | 17,083 | 13,181.4922 | 3,600.2793 | 12.333328 | white | 15 | 16 | 0.820923 | 0.613892 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | no dnr | 24 | 96 | 7.099609 | 96 | 20 | 37 | null | 3.299805 | 0.699951 | 1.099854 | 136 | null | null | null | null | 3 | 0 | SIP>=30 | 0 |
6,063 | 66.34399 | 1 | female | 1 | 14 | 14 | Lung Cancer | Cancer | 1 | 12 | under $11k | 0 | 10,776 | 8,134.1602 | 2,660.4082 | 20.666656 | white | 30.699219 | 53 | 0.343994 | 0.070999 | 1 | 0 | 0 | metastatic | 0.05 | 0.000125 | dnr after sadm | 3 | 59 | 15.599609 | 106 | 40 | 35.29688 | 170 | 1.699951 | 0.299988 | 0.799927 | 138 | 7.25 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
6,064 | 48.76398 | 1 | male | 0 | 5 | 369 | COPD | COPD/CHF/Cirrhosis | 5 | 8 | under $11k | 0 | 4,564 | 3,269.1152 | 1,649.13965 | 17 | white | 12.599609 | 24 | 0.954956 | 0.92395 | 1 | 0 | 0 | no | 1 | 0.75 | no dnr | 5 | 78 | 20.597656 | 75 | 24 | 35.59375 | 208 | 4.599609 | 0.699951 | 1 | 136 | 7.229492 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
6,065 | 47.64999 | 0 | male | 0 | 11 | 1,847 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | null | 0 | 18,079 | 13,855.7578 | 7,969.97656 | 20 | white | 29.097656 | 32 | 0.767944 | 0.69397 | 3 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 11 | 107 | 15.699219 | 110 | 28 | 36.29688 | 147.5 | null | 1.5 | 1 | 132 | 7.419922 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
6,066 | 68.93896 | 1 | male | 0 | 14 | 326 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 3 | under $11k | 0 | 26,031 | 20,241.2969 | 5,496.14844 | 34.333313 | white | 22.5 | 30 | 0.815918 | 0.753906 | 1 | 0 | 0 | no | 0.9 | 0.5 | dnr after sadm | 10 | 106 | null | 106 | 38 | 36.09375 | 187.5 | 3 | 0.699951 | 1.099854 | 142 | 7.349609 | null | null | null | null | null | no(M2 and SIP pres) | 2.572754 |
6,067 | 67.55896 | 1 | male | 0 | 12 | 44 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | $11-$25k | 9 | 30,357 | 22,907.75 | 6,930.06641 | 17.5 | white | 34.195313 | 44 | 0.473999 | 0.35498 | 7 | 0 | 0 | no | 0.9 | 0.6 | no dnr | 12 | 139 | 17.5 | 100 | 24 | 35.09375 | 115 | 2.599609 | 0.899902 | 8 | 134 | 7.40918 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
6,068 | 55.82999 | 1 | female | 0 | 12 | 124 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 8,649 | 6,666.0781 | 2,036.46973 | 2.5 | white | 22.898438 | 31 | 0.769897 | 0.633911 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 12 | 76 | 5.899414 | 94 | 22 | 37.59375 | null | 2 | 6 | 0.799927 | 129 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,069 | 81.25098 | 1 | female | 0 | 10 | 285 | CHF | COPD/CHF/Cirrhosis | 4 | 8 | under $11k | 0 | 7,897 | 5,884.1719 | 2,308.66992 | 16.5 | white | 23.796875 | 55 | 0.747925 | 0.602905 | 1 | 0 | 0 | no | 0.95 | 0.85 | no dnr | 10 | 67 | 14.099609 | 68 | 32 | 36.69531 | 230.46875 | 3.899902 | 1.199951 | 2.899902 | 130 | 7.369141 | null | null | null | 0 | null | null | 0.4948 |
6,070 | 48.92798 | 0 | male | 0 | 9 | 1,839 | CHF | COPD/CHF/Cirrhosis | 5 | 16 | under $11k | 0 | 9,129 | 6,780.3516 | 2,588.39844 | 19.5 | black | 23 | 37 | 0.875977 | 0.792969 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 9 | 129 | 3.799805 | 80 | 16 | 36.29688 | 382.8125 | 3.099609 | 0.5 | 3 | 135 | 7.349609 | null | null | null | 0 | 3 | SIP>=30 | 3 |
6,071 | 77.73895 | 1 | male | 1 | 32 | 32 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | under $11k | 61 | 74,682 | 53,243 | 54,324.0625 | 32.75 | white | 27.199219 | 41 | 0.309998 | 0.196991 | 14 | 1 | 0 | no | 0.8 | 0.5 | no dnr | 32 | 102 | 14.199219 | 117 | 36 | 39.89844 | 433.3125 | 2.399902 | 0.299988 | 0.599976 | 130 | 7.479492 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
6,072 | 61.19897 | 1 | male | 1 | 60 | 60 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 10 | under $11k | 0 | 67,041 | 51,980.4375 | 49,886.2188 | 21.5 | white | 30.199219 | 39 | 0.720947 | 0.634888 | 1 | 0 | 0 | no | 0.8 | 0.5 | dnr after sadm | 43 | 103 | 15.199219 | 111 | 12 | 37.79688 | 126 | 2.699707 | 0.699951 | 6.699219 | 143 | 7.449219 | null | null | null | null | 2 | null | 2 |
6,073 | 64.34497 | 1 | female | 1 | 138 | 138 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 12 | null | 0 | 400,010 | 313,637.5 | 306,945 | 49 | white | 26 | 41 | 0.592896 | 0.484985 | 8 | 0 | 0 | metastatic | 0.8 | 0.4 | dnr after sadm | 112 | 65 | 10.199219 | 114 | 12 | 36.5 | 146.15625 | 2.399902 | 0.5 | 1.599854 | 138 | 7.539062 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
6,074 | 29.62399 | 1 | female | 0 | 6 | 25 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 6,229 | 4,874.7773 | 1,568.46973 | 15 | black | 17.199219 | 30 | 0.939941 | 0.917969 | 1 | 1 | 0 | no | 0.99 | 1 | no dnr | 6 | 62 | 9.298828 | 48 | 24 | 37 | 528.5 | 3 | 0.199982 | 0.799927 | 137 | 7.199219 | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
6,075 | 22.20399 | 0 | female | 0 | 202 | 1,837 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 290,573 | 223,134.375 | 234,875.875 | 35 | white | 28.699219 | 44 | 0.81897 | 0.757935 | 35 | 0 | 0 | no | 0.3 | 0.3 | no dnr | 202 | 144 | 17.898438 | 189 | 28 | 37.79688 | 157.5 | 3 | 0.599976 | 0.599976 | 133 | 7.65918 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
6,076 | 43.064 | 0 | female | 0 | 23 | 1,826 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | under $11k | 0 | 50,118 | 38,679.25 | 36,925.8125 | 31.333328 | white | 28.5 | 45 | 0.786987 | 0.716919 | 4 | 1 | 0 | no | 0.6 | 0.6 | no dnr | 23 | 68 | 15.298828 | 129 | 30 | 37.79688 | 118.71875 | 2.199707 | 0.799927 | 1.099854 | 134 | 7.379883 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,077 | 56.23297 | 0 | male | 0 | 25 | 1,826 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 10 | $11-$25k | 0 | 41,357 | 32,244.8281 | 31,959.9531 | 17 | black | 23.097656 | 44 | 0.845947 | 0.792969 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 25 | 68 | 9.898438 | 80 | 16 | 35.89844 | 366.625 | 4 | 2 | 10.298828 | 131 | 7.389648 | null | null | null | 0 | 4 | no(M2 and SIP pres) | 4 |
6,078 | 72.91998 | 1 | female | 0 | 10 | 17 | MOSF w/Malig | ARF/MOSF | 3 | 8 | under $11k | 0 | 8,968 | 6,329.0781 | 6,522.59766 | 12 | white | 22.898438 | 26 | 0.645996 | 0.545898 | 1 | 0 | 0 | metastatic | 0.25 | 0.1 | dnr after sadm | 2 | 101 | 19.699219 | 108 | 20 | 36.29688 | 266.625 | 2 | 1 | 0.5 | 137 | 7.279297 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
6,079 | 64.52594 | 1 | female | 0 | 12 | 1,041 | MOSF w/Malig | ARF/MOSF | 1 | 10 | $11-$25k | 0 | 17,900 | 14,150.2969 | 13,078.3438 | 35 | white | 26.796875 | 59 | 0.636963 | 0.534912 | 1 | 0 | 0 | yes | 0.5 | 0.5 | no dnr | 12 | 67 | 13.099609 | 107 | 14 | 36.69531 | 356.625 | 1.799805 | 3 | 2.899902 | 139 | 7.329102 | null | null | null | null | null | no(M2 and SIP pres) | 2.302246 |
6,080 | 66.11896 | 1 | female | 0 | 5 | 236 | Lung Cancer | Cancer | 2 | 12 | under $11k | 0 | 4,149 | 2,941.3828 | 2,864.25977 | 9 | black | 18.199219 | 15 | 0.680908 | 0.385986 | 1 | 1 | 0 | metastatic | 0.8 | 0.3 | dnr after sadm | 1 | 95 | 10.5 | 66 | 24 | 37.79688 | 257.125 | 3.199707 | 0.399963 | 0.699951 | 139 | 7.469727 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,081 | 73.71698 | 1 | female | 0 | 6 | 26 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 3,515 | 2,652.0137 | 2,428.92969 | 7 | white | 28.199219 | 35 | 0.393982 | 0.099991 | 1 | 0 | 0 | metastatic | 0.5 | 0.4 | dnr after sadm | 1 | 76 | 7.099609 | 114 | 24 | 36.39844 | 227.125 | 3 | 0.399963 | 0.5 | 132 | 7.469727 | null | null | null | 6 | 5 | <2 mo. follow-up | 5 |
6,082 | 64.849 | 1 | female | 0 | 20 | 54 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 44 | 37,256 | 28,256.3594 | 27,181.4375 | 29 | black | 35.296875 | 55 | 0.303955 | 0.191986 | 4 | 0 | 0 | no | 0.3 | 0.2 | no dnr | 20 | 54 | 12.398438 | 111 | 30 | 35 | 300 | 2.699707 | 1.599854 | 2.799805 | 142 | 7.40918 | null | null | null | 5 | 5 | adl>=4 (>=5 if sur) | 5 |
6,083 | 68.85095 | 0 | male | 0 | 16 | 1,821 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 11 | under $11k | 0 | 15,825 | 11,496.8828 | 11,094.9531 | 16 | white | 24.398438 | 34 | 0.689941 | 0.5979 | 5 | 0 | 0 | yes | 0.9 | 0.8 | no dnr | 16 | 85 | 11.199219 | 56 | 20 | 36.09375 | 275 | 2.299805 | 6.399414 | 1.199951 | 138 | 7.519531 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
6,084 | 65.487 | 1 | female | 0 | 4 | 28 | Lung Cancer | Cancer | 3 | 11 | null | 0 | 7,190 | 2,025.7129 | 1,854.90918 | 15 | black | 10.798828 | 17 | 0.809937 | 0.593994 | 1 | 0 | 0 | metastatic | 0.25 | 0.05 | dnr after sadm | 1 | 103 | 3.599609 | 108 | 20 | 36.5 | 267.5625 | 4.099609 | 0.699951 | 0.899902 | 139 | 7.389648 | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
6,085 | 73.32495 | 1 | female | 0 | 5 | 1,070 | CHF | COPD/CHF/Cirrhosis | 5 | 14 | under $11k | 0 | 3,602 | 2,656.4199 | 2,451.34961 | 9 | black | 21.097656 | 32 | 0.779907 | 0.647949 | 1 | 1 | 0 | yes | 1 | 0.7 | no dnr | 5 | 119 | 7.599609 | 78 | 24 | 36 | 386.1875 | 3.399902 | 0.299988 | 3.699707 | 139 | 7.369141 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
6,086 | 51.26099 | 1 | male | 0 | 6 | 1,409 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 5,223 | 3,622.3848 | 4,110.12891 | 16 | black | 12.898438 | 15 | 0.939941 | 0.897949 | 1 | 0 | 0 | no | 1 | 0.85 | no dnr | 6 | 75 | 8.798828 | 96 | 24 | 36 | 314.75 | 4.199219 | 1.199951 | 1 | 137 | 7.399414 | null | null | null | 4 | 5 | null | 5 |
6,087 | 50.69098 | 1 | female | 0 | 10 | 79 | Lung Cancer | Cancer | 4 | 11 | $11-$25k | 0 | 9,506 | 6,553.1758 | 6,873.66797 | 13 | black | 16.5 | 44 | 0.748901 | 0.488953 | 1 | 0 | 0 | metastatic | 0.6 | 0.3 | no dnr | 10 | 60 | 0.899902 | 112 | 30 | 39.19531 | 352.375 | 3.699707 | 0.599976 | 0.899902 | 138 | 7.389648 | null | null | null | 4 | 0 | SIP>=30 | 0 |
6,088 | 66.67999 | 1 | female | 1 | 20 | 20 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 6 | under $11k | 0 | 57,846 | 41,928.1875 | 44,372.3125 | 46.666657 | white | 39.5 | 71 | 0.334961 | 0.219971 | 19 | 0 | 0 | no | 0.2 | 0.2 | dnr after sadm | 19 | 125 | 23 | 120 | 28 | 35.5 | 230.65625 | 2.799805 | 11.298828 | 2.099609 | 128 | 7.40918 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,089 | 67.27399 | 1 | female | 1 | 18 | 18 | MOSF w/Malig | ARF/MOSF | 3 | null | null | 44 | 55,395 | 39,613.875 | 37,132.875 | 53.666657 | white | 35.695313 | 66 | 0.047997 | 0.014999 | 12 | 1 | 0 | metastatic | 0.5 | 0 | dnr after sadm | 16 | 54 | 12.398438 | 130 | 24 | 38.29688 | 98.79688 | 1.699951 | 2.599609 | 1.5 | 132 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 4.148438 |
6,090 | 56.80197 | 1 | male | 0 | 8 | 1,657 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 13 | under $11k | 0 | 5,660 | 4,237.1289 | 3,937.18945 | 5.5 | white | 24.796875 | 36 | 0.730957 | 0.578979 | 1 | 1 | 0 | no | 0.95 | 0.9 | no dnr | 8 | 73 | 13.398438 | 72 | 16 | 38.19531 | null | 3.099609 | 8.599609 | 0.599976 | 130 | null | null | null | null | 5 | 4 | no(M2 and SIP pres) | 4 |
6,091 | 62.672 | 0 | female | 0 | 17 | 1,819 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 14,477 | 10,420.1484 | 8,907.67969 | 8.333328 | white | 24.699219 | 34 | 0.689941 | 0.522949 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 17 | 75 | 13.199219 | 62 | 28 | 36.59375 | 342.8125 | 2.899902 | 4.299805 | 0.699951 | 131 | 7.469727 | null | null | null | null | null | no(M2 and SIP pres) | 3.400879 |
6,092 | 63.81897 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 41 | 34,153 | 25,040.625 | 25,694.5156 | 78 | black | 42.898438 | 87 | 0.084 | 0.032997 | 20 | 1 | 0 | no | null | null | no dnr | 4 | 141 | 17.5 | 144 | 50 | 38.69531 | 70.1875 | 2.5 | 0.899902 | 4.699219 | 131 | 7.239258 | null | null | null | null | null | <2 mo. follow-up | 3.804199 |
6,093 | 54.13599 | 1 | male | 0 | 13 | 1,363 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 9 | under $11k | 41 | 18,031 | 15,195.3438 | 14,238.0234 | 26.5 | black | 23.097656 | 20 | 0.747925 | 0.668945 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 13 | 119 | 17 | 131 | 30 | 38.59375 | 217.9375 | 2.5 | 0.399963 | 0.599976 | 139 | 7.389648 | null | null | null | null | 6 | null | 6 |
6,094 | 70.52997 | 0 | female | 0 | 16 | 1,816 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 10 | under $11k | 0 | 27,348 | 19,935.2812 | 19,630.7812 | 16.666656 | white | 30.796875 | 40 | 0.501953 | 0.384949 | 9 | 1 | 0 | yes | 0.95 | 0.85 | no dnr | 16 | 131 | 16 | 114 | 30 | 36 | 114.28125 | 2.5 | 0.599976 | 1.099854 | 133 | 7.449219 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
6,095 | 65.94397 | 1 | female | 1 | 43 | 43 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 43,172 | 32,274.2969 | 30,522 | 8 | black | 23 | 28 | 0.699951 | 0.536987 | 1 | 0 | 0 | no | 0.5 | 0.25 | no dnr | 43 | 119 | 5.299805 | 104 | 20 | 36.39844 | null | 2.199707 | 6.899414 | 0.899902 | 138 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
6,096 | 61.69998 | 1 | female | 1 | 9 | 9 | Coma | Coma | 2 | null | null | 100 | 39,025 | 31,000.5625 | 29,116.8906 | 44 | white | 26.097656 | 43 | 0.100998 | 0.059998 | 12 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 4 | 145 | 20.597656 | 153 | 32 | 40.29688 | 242.71875 | 2.299805 | 0.399963 | 0.599976 | 147 | 7.399414 | null | null | null | null | null | <2 mo. follow-up | 3.353516 |
6,097 | 75.83295 | 1 | female | 1 | 11 | 11 | MOSF w/Malig | ARF/MOSF | 2 | 6 | under $11k | 100 | 14,140 | 10,036.8438 | 10,409.5391 | 18.5 | black | 29.296875 | 75 | 0.021 | 0.004999 | 5 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 3 | 70 | 11.798828 | 72 | 32 | 32.39844 | 293.3125 | 2.199707 | 2.899902 | 1.299805 | 139 | 7.179688 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
6,098 | 81.44598 | 0 | female | 0 | 10 | 1,811 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | under $11k | 0 | 13,105 | 10,368.3516 | 9,926.22656 | 11.5 | white | 17 | 21 | 0.845947 | 0.793945 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 10 | 63 | 9.5 | 69 | 24 | 36 | 318.3125 | 4 | 0.699951 | 1.299805 | 135 | 7.439453 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,099 | 77.008 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 9 | under $11k | 9 | 20,080 | 15,475.9531 | 15,057.9688 | 19 | white | 18.199219 | 22 | 0.790894 | 0.721924 | 5 | 1 | 1 | no | 0.85 | 0.85 | no dnr | 11 | 126 | 6.599609 | 67 | 24 | 36 | 328.5625 | 2.699707 | 0.799927 | 0.899902 | 132 | 7.449219 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
6,100 | 46.20099 | 1 | female | 0 | 19 | 1,527 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 0 | 16,140 | 12,431.75 | 11,075.5391 | 10.333328 | white | 29.398438 | 37 | 0.793945 | 0.726929 | 1 | 1 | 0 | no | 0.9 | 0.85 | no dnr | 19 | 114 | 5 | 118 | 28 | 36 | 300 | 2.599609 | 3 | 0.5 | 135 | 7.419922 | null | null | null | null | null | null | 4.115234 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.